Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$236,709
+$168,651 QoQ
Shares Held
48,806
+14.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 114 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ZNTL ranks #230 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in ZNTL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $236,709 48,806
2025-03-31 $68,058 42,804
2024-12-31 $129,696 42,804
2024-09-30 $117,506 31,931
2024-06-30 $97,125 23,747
2024-03-31 $485,801 30,825
2023-12-31 $650,025 42,906
2023-09-30 $643,524 32,080
2023-06-30 $11,826,364 419,226
2023-03-31 $770,972 44,824
2022-12-31 $753,155 37,396
2022-09-30 $1,487,044 68,654
2022-06-30 $633,035 22,528
2022-03-31 $1,529,632 33,152
2021-12-31 $2,940,922 34,986
2021-09-30 $2,252,630 33,803
2021-06-30 $1,189,816 22,365
2021-03-31 $934,359 21,534
2020-12-31 $1,214,200 23,377
2020-09-30 $204,475 6,255
2020-06-30 $251,432 5,236